Entry of ketoconazole into Candida albicans
- 1 February 1987
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 31 (2) , 244-248
- https://doi.org/10.1128/aac.31.2.244
Abstract
To define characteristics that determine the entry of ketoconazole (KTZ) into Candida albicans cells, we studied the uptake of [3H]KTZ. The cells rapidly and markedly concentrated the drug: 30% of the final 80-fold intracellular concentration was attained in less than 1 min, and greater than 60% was attained in 10 min. Penetration of [3H]KTZ at an extracellular concentration higher than 0.1875 microM (0.1 microgram/ml) occurred by a simple diffusion mechanism. At lower concentrations, accumulation of the drug was an active, energy-requiring process, dependent at least in part on glycolysis, and pH dependent (optimal pH, 6.6). The active transport system had a high binding affinity (Km = 50 nM) and a high maximum velocity of uptake (Vmax = 1.4 mumol min-1 10(-7) cells). It was not possible to displace intracellular [3H]KTZ with high concentrations of unlabeled KTZ or other antifungal agents. These findings suggest that KTZ is rapidly taken up, highly concentrated, and tightly bound to cellular components of C. albicans.This publication has 11 references indexed in Scilit:
- Direct membrane-damaging effect of ketoconazole and tioconazole on Candida albicans demonstrated by bioluminescent assay of ATPAntimicrobial Agents and Chemotherapy, 1984
- Hypothesis on the molecular basis of the antifungal activity of N-substituted imidazoles and triazolesBiochemical Society Transactions, 1983
- Laboratory and clinical assessment of ketoconazole in deep-seated mycosesThe American Journal of Medicine, 1983
- Combination Therapy of Experimental Histoplasmosis and Cryptococcosis with Amphotericin Band KetoconazoleClinical Infectious Diseases, 1980
- In vitro synergy and antagonism of antifungal agents against yeast-like fungiPublished by Oxford University Press (OUP) ,1979
- Ketoconazole — a new broad spectrum orally active antimycoticCellular and Molecular Life Sciences, 1979
- Comparison of the in Vitro Antifungal Activities of Miconazole and a New Imidazole, R41,400The Journal of Infectious Diseases, 1978
- ANTAGONISM BETWEEN MICONAZOLE AND AMPHOTERICIN BThe Lancet, 1976
- Synergistic Action of Amphotericin Band Rifampin against Candida SpeciesThe Journal of Infectious Diseases, 1976
- Synergistic Action of Amphotericin B and 5-Fluorocytosine Against Yeast-Like OrganismsExperimental Biology and Medicine, 1971